Dr. Evan Haney
Chief Scientific Officer
Dr. Haney is an experienced scientist and research coordinator who has managed a team of up to 20 individuals over the past 10 years. He is an inventor on the peptide patents that are core to ABT’s therapeutic technology and has in-depth experience with the various endeavors relevant to clinical research. He has published over 40 papers in scientific journals, including two major reviews in Nature journals related to peptide optimization and their development as therapeutics. Dr. Haney holds a Ph.D. in Biochemistry from the University of Calgary.